Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapies

Mogrify raises additional $16 million to advance its mission to transform the development of life-saving cell therapies2019-10-14T13:59:36+00:00

Mogrify subsidiary Chondrogenix secures funding from SBRI Healthcare to advance regenerative cartilage therapy to the clinic

Mogrify subsidiary Chondrogenix secures funding from SBRI Healthcare to advance regenerative cartilage therapy to the clinic2019-09-26T08:47:29+00:00

Mogrify raises $3.7 million USD seed funding to accelerate its mission to transform cell therapy via direct cellular conversion

Mogrify raises $3.7 million USD seed funding to accelerate its mission to transform cell therapy via direct cellular conversion2019-09-06T10:09:41+00:00